BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 17100612)

  • 1. CRF1 receptors as a therapeutic target for irritable bowel syndrome.
    Martinez V; Taché Y
    Curr Pharm Des; 2006; 12(31):4071-88. PubMed ID: 17100612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of corticotropin releasing factor receptor subtype 1 in stress-related functional colonic alterations: implications in irritable bowel syndrome.
    Taché Y; Martinez V; Million M; Maillot C
    Eur J Surg Suppl; 2002; (587):16-22. PubMed ID: 16144197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered colonic sensory and barrier functions by CRF: roles of TLR4 and IL-1.
    Nozu T; Miyagishi S; Nozu R; Takakusaki K; Okumura T
    J Endocrinol; 2018 Nov; 239(2):241-252. PubMed ID: 30139928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corticotropin-releasing factor receptor type 1 and type 2 interaction in irritable bowel syndrome.
    Nozu T; Okumura T
    J Gastroenterol; 2015 Aug; 50(8):819-30. PubMed ID: 25962711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corticotropin-releasing factor receptor 1 (CRF-R1) antagonists: Promising agents to prevent visceral hypersensitivity in irritable bowel syndrome.
    Lv Y; Wen J; Fang Y; Zhang H; Zhang J
    Peptides; 2022 Jan; 147():170705. PubMed ID: 34822913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of corticotropin-releasing factor pathways in stress-related alterations of colonic motor function and viscerosensibility in female rodents.
    Taché Y; Million M; Nelson AG; Lamy C; Wang L
    Gend Med; 2005 Sep; 2(3):146-54. PubMed ID: 16290887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticotropin-releasing factor 1 receptor-mediated mechanisms inhibit colonic hypersensitivity in rats.
    Greenwood-Van Meerveld B; Johnson AC; Cochrane S; Schulkin J; Myers DA
    Neurogastroenterol Motil; 2005 Jun; 17(3):415-22. PubMed ID: 15916629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From Hans Selye's discovery of biological stress to the identification of corticotropin-releasing factor signaling pathways: implication in stress-related functional bowel diseases.
    Taché Y; Brunnhuber S
    Ann N Y Acad Sci; 2008 Dec; 1148():29-41. PubMed ID: 19120089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRF1 receptor signaling pathways are involved in stress-related alterations of colonic function and viscerosensitivity: implications for irritable bowel syndrome.
    Taché Y; Martinez V; Wang L; Million M
    Br J Pharmacol; 2004 Apr; 141(8):1321-30. PubMed ID: 15100165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visceral hypersensitivity in irritable bowel syndrome.
    Kanazawa M; Hongo M; Fukudo S
    J Gastroenterol Hepatol; 2011 Apr; 26 Suppl 3():119-21. PubMed ID: 21443723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Don't stress about CRF: assessing the translational failures of CRF
    Spierling SR; Zorrilla EP
    Psychopharmacology (Berl); 2017 May; 234(9-10):1467-1481. PubMed ID: 28265716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic psychosocial stress induces reversible mitochondrial damage and corticotropin-releasing factor receptor type-1 upregulation in the rat intestine and IBS-like gut dysfunction.
    Vicario M; Alonso C; Guilarte M; Serra J; Martínez C; González-Castro AM; Lobo B; Antolín M; Andreu AL; García-Arumí E; Casellas M; Saperas E; Malagelada JR; Azpiroz F; Santos J
    Psychoneuroendocrinology; 2012 Jan; 37(1):65-77. PubMed ID: 21641728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of enteric neurons by interleukin-6 and corticotropin-releasing factor contributes to visceral hypersensitivity and altered colonic motility in a rat model of irritable bowel syndrome.
    Buckley MM; O'Halloran KD; Rae MG; Dinan TG; O'Malley D
    J Physiol; 2014 Dec; 592(23):5235-50. PubMed ID: 25260633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corticotropin-releasing factor type 1 receptors mediate the visceral hyperalgesia induced by repeated psychological stress in rats.
    Larauche M; Bradesi S; Million M; McLean P; Taché Y; Mayer EA; McRoberts JA
    Am J Physiol Gastrointest Liver Physiol; 2008 Apr; 294(4):G1033-40. PubMed ID: 18308857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corticotrophin-releasing factor 1 activation in the central amygdale and visceral hyperalgesia.
    Taché Y
    Neurogastroenterol Motil; 2015 Jan; 27(1):1-6. PubMed ID: 25557223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pain is a salient "stressor" that is mediated by corticotropin-releasing factor-1 receptors.
    Hummel M; Cummons T; Lu P; Mark L; Harrison JE; Kennedy JD; Whiteside GT
    Neuropharmacology; 2010 Sep; 59(3):160-6. PubMed ID: 20470804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The newly developed CRF1-receptor antagonists, NGD 98-2 and NGD 9002, suppress acute stress-induced stimulation of colonic motor function and visceral hypersensitivity in rats.
    Million M; Zhao JF; Luckey A; Czimmer J; Maynard GD; Kehne J; Hoffman DC; Taché Y
    PLoS One; 2013; 8(9):e73749. PubMed ID: 24040053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do corticotropin releasing factor-1 receptors influence colonic transit and bowel function in women with irritable bowel syndrome?
    Sweetser S; Camilleri M; Linker Nord SJ; Burton DD; Castenada L; Croop R; Tong G; Dockens R; Zinsmeister AR
    Am J Physiol Gastrointest Liver Physiol; 2009 Jun; 296(6):G1299-306. PubMed ID: 19342506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral corticotropin-releasing factor and stress-stimulated colonic motor activity involve type 1 receptor in rats.
    Maillot C; Million M; Wei JY; Gauthier A; Taché Y
    Gastroenterology; 2000 Dec; 119(6):1569-79. PubMed ID: 11113078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crosstalk between interleukin-6 and corticotropin-releasing factor modulate submucosal plexus activity and colonic secretion.
    O'Malley D; Cryan JF; Dinan TG
    Brain Behav Immun; 2013 May; 30():115-24. PubMed ID: 23369733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.